ASSET terminates GMO, Macquarie mandates, seeks to insource rebalancing

ASSET Super has terminated a $45 million Australian equities mandate with GMO, and made an appointment aimed at allowing it to insource its passive rebalancing of portfolios.

The money that ASSET previously allocated to GMO’s core momentum Australian equities fund has been parceled out among Australian equities vehicles run by the following managers: Schroder Investment Management ($20 million), Quest Asset Partners ($15 million) and Challenger Financial Services ($10 million). “It’s a continuation of our strategy to get as much value as we can for members…We decided [GMO] weren’t delivering what we required,” John Paul, ASSET chief executive officer, said. The $1.6 billion industry fund, which uses Intech as its asset consultant, also took a $100 million cash mandate away from Macquarie Bank in May, directing $55 million of the money to ING Investment Management and $45 million to Perpetual Investments. Meanwhile, the fund last month hired Vijay Vittal, an accountant who previously worked at Citistreet, to monitor ASSET’s weekly unit prices and, in time, take passive rebalancing duties from National Custodian Services, the fund’s custodian.

, , , , , , , , , , ,

Leave a Comment

How Cbus built its new Australian equity strategy from scratch

Ryan Riedler, head of ASX core strategy, Australian equities at Cbus, says the fund will look to generate alpha locally through engagement and that internalisation will help it strengthen its connection with other market participants, as well as its brokers and service providers.

Sort content by